Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamic and pharmacokinetic study comparing extended-release BiDil capsules with commercial BiDiL tablets in heart failure patients has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BIDIL (Hydralazine hydrochloride and isosorbide dinitrate)

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Heart Failure | Phase 1 | Status: COMPLETED